| Symbol | UCBJY |
|---|---|
| Name | UCB S.A. |
| Sector | UNDEFINED |
| Region | Europe |
| Industry | - |
| Address | 1070 Belgium Allee de la Recherche 60 |
| Telephone | 322-559-9999 |
| Fax | — |
| — | |
| Website | http://www.ucb.com |
| Incorporation | BE |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Euronext Brussels |
| CIK | 0001290640 |
| Description | UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. Additional info from OTC: |
Pink Limited symbol attribute type Security_Name was changed. Previous value: -. New value: UCB SA UNSP/ADR.
Read morePink Limited symbol attribute type Security_Name was changed. Previous value: -. New value: UCB SA NPV.
Read moreOTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: UCB SA UNSP/ADR.
Read moreOTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: UCB SA NPV.
Read more